Evidence map›Paper›PMID 30128947›Full record

ArticleThe journal of headache and pain2018

Anodal frontal tDCS for chronic cluster headache treatment: a proof-of-concept trial targeting the anterior cingulate cortex and searching for nociceptive correlates.

Delphine Magis, Kevin D'Ostilio, Marco Lisicki, Chany Lee, Jean Schoenen

Open access · goldAbstract read
In one paragraph

Article in The journal of headache and pain, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Hallmarks of primary headache: part 3 - cluster headache.The journal of headache and pain · 2025
    Review
  2. Review
  3. Pain Lateralization in Cluster Headache and Associated Clinical Factors.Journal of clinical neurology (Seoul, Korea) · 2025
    Article
  4. Low-Intensity Focused Ultrasound to the Human Dorsal Anterior Cingulate Attenuates Acute Pain Perception and Autonomic Responses.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  5. Article
  6. Article
  7. Neuromodulation for Chronic Daily Headache.Current pain and headache reports · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Delphine MagisHeadache Research Unit, University Department of Neurology CHR, CHU de Liège, Boulevard du 12ème de Ligne 1, 4000, Liège, Belgium. dmagis@chuliege.be.ORCID http://orcid.org/0000-0002-4392-9413
Kevin D'OstilioHeadache Research Unit, University Department of Neurology CHR, CHU de Liège, Boulevard du 12ème de Ligne 1, 4000, Liège, Belgium.
Marco LisickiHeadache Research Unit, University Department of Neurology CHR, CHU de Liège, Boulevard du 12ème de Ligne 1, 4000, Liège, Belgium.
Chany LeeDepartment of Biomedical Engineering, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul, 04763, South Korea.
Jean SchoenenHeadache Research Unit, University Department of Neurology CHR, CHU de Liège, Boulevard du 12ème de Ligne 1, 4000, Liège, Belgium.
University of Liège · BEHanyang University · KR

Funding

Fondation Roi Baudouin Fonds Malou Malou
6 · The paper itself

Abstract

backgroundPercutaneous occipital nerve stimulation (ONS) is effective in refractory chronic cluster headache (rCCH) patients. Responders to ONS differ from non-responders by greater glucose metabolism in subgenual anterior cingulate cortex (sgACC). We reasoned that transcranial direct current stimulation (tDCS), a non-invasive approach, might be able to activate this area and thus improve rCCH patients. Our objective was to explore in a pilot trial the therapeutic potential of tDCS (anode at Fz, cathode over C7) and its possible effects on pain perception, frontal executive functions and mood in rCCH patients.

methodsThirty-one patients were asked to apply daily 20-min sessions of 2 mA tDCS for 4 or 8 weeks after a 1-month baseline. CH attacks were monitored with paper diaries. The primary outcome measure was change in weekly attacks between baseline and the last week of tDCS. Twenty-three patients were available for a modified ITT analysis, 21 for per-protocol analysis. We also explored treatment-related changes in thermal pain thresholds and nociceptive blink reflexes (nBR), frontal lobe function and mood scales.

resultsIn the per-protocol analysis there was a mean 35% decrease of attack frequency (p = 0.0001) with 41% of patients having a ≥ 50% decrease. Attack duration and intensity were also significantly reduced. After 8 weeks (n = 10), the 50% responder rate was 45%, but at follow-up 2 weeks after tDCS (n = 16) mean attack frequency had returned to baseline levels. The treatment effect was significant in patients with high baseline thermal pain thresholds in the forehead (n = 12), but not in those with low thresholds (n = 9). The Frontal Assessment Battery score increased after tDCS (p = 0.01), while there was no change in depression scores or nBR.

conclusiontDCS with a Fz-C7 montage may have a preventive effect in rCCH patients, especially those with low pain sensitivity, suggesting that a sham-controlled trial in cluster headache is worthwhile. Whether the therapeutic effect is due to activation of the sgACC that can in theory be reached by the electrical field, or of other prefrontal cortical areas remains to be determined.

Indexed as

Proof of Concept StudyAdultBrain MappingChronic DiseaseCluster HeadacheFemaleGyrus CinguliHumansMaleMiddle AgedPain MeasurementPain PerceptionTranscranial Direct Current StimulationChronic cluster headacheSubgenual anterior cingulate cortexTranscranial direct current stimulation

Identifiers

PMID30128947
PMCPMC6102161
OpenAlexW2888462516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.